Ensign Peak Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Ensign Peak Advisors's HRMY Position: Q3 2026 in Review
Ensign Peak Advisors held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 3,535 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.
Ensign Peak Advisors first reported a position in HRMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $629K in Q4 2022. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Ensign Peak Advisors held 3,535 shares of Harmony Biosciences worth $139K as of Q3 2026.
- Ensign Peak Advisors left its Harmony Biosciences share count unchanged in Q3 2026.
- Harmony Biosciences made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #1534 holding.
- Ensign Peak Advisors first reported a position in Harmony Biosciences in Q4 2021 and has held it in 20 quarters since.
- Ensign Peak Advisors's Harmony Biosciences position peaked at $629K in Q4 2022.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.